Also trades as: BUX.CN (CNQ) · $vol 0M
BMKDF OTC
BioMark Diagnostics Inc.
1W: +6.8%
1M: +7.2%
3M: -6.0%
YTD: +12.5%
1Y: +60.8%
3Y: +81.2%
5Y: +92.9%
$0.39
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$60K
-61.2% ▼
Gross Profit
$60K
-61.2% ▼
Operating Income
-$1M
+23.6% ▲
Net Income
-$1M
+23.4% ▲
EPS (Diluted)
$-0.01
+29.5% ▲
EBITDA
-$1M
+29.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $44K | $153K | $163K | $154K | $60K |
| YoY Growth | +0.0% | +249.4% | +6.3% | -5.5% | -61.2% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $44K | $153K | $163K | $154K | $60K |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D Expenses | $498K | $546K | $651K | $696K | $668K |
| SG&A Expenses | $565K | $959K | $722K | $999K | $547K |
| Operating Expenses | $1M | $2M | $1M | $2M | $2M |
| Operating Income | -$1M | -$2M | -$1M | -$2M | -$1M |
| Operating Margin | -3193.7% | -1128.4% | -806.1% | -1237.3% | -2436.8% |
| Interest Expense | $50K | $110K | $115K | $62K | $63K |
| Income Before Tax | -$1M | -$2M | -$1M | -$2M | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$2M | -$1M | -$2M | -$1M |
| Net Margin | -3309.4% | -1200.2% | -874.5% | -1249.7% | -2470.8% |
| EPS (Diluted) | $-0.02 | $-0.02 | $-0.02 | $-0.02 | $-0.01 |
| EBITDA | -$1M | -$1M | -$919K | -$1M | -$1M |
| Shares Outstanding | 72M | 83M | 85M | 91M | 105M |